Olesya Ilkun

Olesya Ilkun, M.D., Ph.D., FASN

CLIN AST PROF

Department: MD-NEPHROLOGY
Business Phone: (352) 273-8821
Business Email: o.ilkun@ufl.edu

About Olesya Ilkun

I am a board-certified nephrologist and assistant professor in the University of Florida Division of Nephrology, Hypertension & Renal Transplantation. My clinical interests include chronic kidney disease, those who have had an organ transplantation (lung, liver and heart), hypertension, metabolic diseases and end stage renal disease. I aim to provide the highest quality of care for my patients.

I earned my doctoral degree, studying insulin resistance and mitochondrial function in the context of diabetes and heart disease, and medical degree from the University of Utah. Subsequently, I completed an internal medicine residency, where I developed interests in vascular disease, hypertension and nephrology, and thereafter completed a nephrology fellowship. I was the recipient of the T32 NIH funding and the Kidney Stars award from the American Society of Nephrology.

After completing my training, I joined the Division of Nephrology, Hypertension & Renal Transplantation at UF. I teach nephrology fellows, medical students and physician assistant students, and received a 2023 Exemplary Teacher award by the UF College of Medicine. Additionally, I author and co-author a variety of publications, present at national and international conferences, and have been recognized as a Fellow of the American Society of Nephrology (FASN).

Teaching Profile

Courses Taught
2022-2025
PAS5010 Intro to Medicine 1
2024
BMS6638C Kidney & Urinary Tract

Board Certifications

  • Internal Medicine
    American Board of Internal Medicine
  • Nephrology
    American Board of Internal Medicine

Clinical Profile

Olesya Ilkun, MD, PhD, is an Assistant Professor at the University of Florida College of Medicine.

Dr. Ilkun graduated from the University of Utah with her PhD degree in 2011 where she studied insulin resistance and mitochondrial function in the context of diabetes and heart disease. She then stayed at the University of Utah to pursue her MD degree. During her Internal Medicine residency training at the same institution, she developed her interests in vascular disease, hypertension and Nephrology. She further specialized through a fellowship in Nephrology at the University of Utah.

After completing her training, Dr. Ilkun joined the Division of Nephrology, Hypertension & Renal Transplantation at the University of Florida as an Assistant Professor. Dr. Ilkun is board certified in both Internal Medicine and Nephrology by the American Board of Internal Medicine. She was recognized as a Fellow of the American Society of Nephrology (FASN). She was the recipient of the T32 NIH funding and the Kidney Stars award from the American Society of Nephrology.

Dr. Ilkun’s goal is to provide the highest quality of care to her patients. Her clinical interests include treating patients with chronic kidney disease who had organ transplantation (lung(s), liver, heart), as well as patients with hypertension, metabolic diseases, and end stage renal disease.

Dr. Ilkun gives lectures for Nephrology fellows, medical students and physician assistant students at the University of Florida. She authored and co-authored a variety of publications and has presented her research findings at national and international conferences.

Specialties
  • Nephrology

Publications

Academic Articles
2025
Uremic Leontiasis Ossea due to Resistant Secondary Hyperparathyroidism.
AACE clinical case reports. 11(1):5-9 [DOI] 10.1016/j.aace.2024.09.001. [PMID] 39896948.
2015
Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome.
Journal of molecular and cellular cardiology. 85:104-16 [DOI] 10.1016/j.yjmcc.2015.05.012. [PMID] 26004364.
2014
Treatment with a SOD mimetic reduces visceral adiposity, adipocyte death, and adipose tissue inflammation in high fat-fed mice.
Obesity (Silver Spring, Md.). 22(1):178-87 [DOI] 10.1002/oby.20465. [PMID] 23526686.
2013
Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.
Current pharmaceutical design. 19(27):4806-17 [PMID] 23323621.
2013
Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation.
Molecular endocrinology (Baltimore, Md.). 27(1):172-84 [DOI] 10.1210/me.2012-1210. [PMID] 23204326.
2013
Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth.
PloS one. 8(1) [DOI] 10.1371/journal.pone.0054221. [PMID] 23342106.
2009
Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.
Cardiovascular research. 82(2):351-60 [DOI] 10.1093/cvr/cvp017. [PMID] 19147655.

Education

Fellowship, Nephrology
2020-2022 · University of Utah
Residency, Internal Medicine
2018-2020 · University of Utah
Intern, Internal Medicine
2017-2018 · University of Utah
Medical School
2013-2017 · University of Utah School of Medicine
Doctoral, Biochemistry
2005-2011 · University of Utah
Master of Science, Organic Chemistry
2004-2005 · Taras Shevchenko Kiev National University

Contact Details

Phones:
Business:
(352) 273-8821
Emails:
Business:
o.ilkun@ufl.edu
Addresses:
Business Street:
P.O. Box 100224
Division of Nephrology, Hypertension, & Renal Transplan
GAINESVILLE FL 32611